معرفی
Tenzin Choden is an Assistant Professor in the Department of Medicine (Gastroenterology) at the University of Chicago. Her research primarily focuses on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, with an emphasis on clinical outcomes, novel therapeutics, and endoscopic assessment.
Her research interests span a wide range of topics within gastroenterology, particularly inflammatory bowel disease. Key areas include the use of Janus kinase inhibitors and sphingosine-1 phosphate receptor modulators for IBD treatment, the impact of proton pump inhibitors on IBD outcomes, monitoring IBD during pregnancy, and the application of artificial intelligence in IBD endoscopy. She also investigates healthcare access issues such as prior authorization delays and the association between IBD and neurological disorders or checkpoint inhibitor colitis.
Analysis of her recent publications (2022-2024) reveals a strong focus on clinical research in IBD therapeutics and management. There is a trend towards real-world data studies evaluating new drugs (like ozanimod and JAK inhibitors) and endoscopic healing indices. Additionally, she explores interdisciplinary connections, such as the link between IBD and neurological conditions, and the challenges of managing IBD in special populations including pregnant women and patients receiving immunotherapy.
Regarding advising and grants, no specific information is available in the provided text. Similarly, details about laboratory facilities or research teams are not mentioned.
